APO Research
Talk to an analyst

APO RESEARCH · REPORT

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Growth and Trends Forecast to 2032

29 December 2025107 pages

Choose your research edition.

Industry ResearchPIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine include Bioveta, Boehringer Ingelheim, CAVAC, Ceva Santé Animale, HIPRA, Jinyu Bio-Technology, Sinopharm Animal Health Co., Ltd, Zoetis and Harbin Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Company

Bioveta

Boehringer Ingelheim

CAVAC

Ceva Santé Animale

HIPRA

Jinyu Bio-Technology

Sinopharm Animal Health Co., Ltd

Zoetis

Harbin Pharmaceutical Group

Merck

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type

CH-1R Strain

PC Strain

Others

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application

Gilts

Sows

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of CH-1R Strain Table 2. Major Company of PC Strain Table 3. Major Company of Others Table 4. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2026) & (US$/Unit) Table 10. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (K Units) Table 11. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2027-2032) & (US$/Unit) Table 15. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 16. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 18. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends Table 26. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers Table 27. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges Table 28. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints Table 29. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Company (2021-2026) & (K Units) Table 32. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Company (2021-2026) Table 33. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Company Production Sites and Headquarters Table 36. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company, Product Type & Application Table 37. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2027-2032) & (K Units) Table 47. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 53. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (K Units) Table 58. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2027-2032) & (US$/Unit) Table 62. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 63. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 65. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 69. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Bioveta Company Information Table 73. Bioveta Business Overview Table 74. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 76. Bioveta Recent Development Table 77. Boehringer Ingelheim Company Information Table 78. Boehringer Ingelheim Business Overview Table 79. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 81. Boehringer Ingelheim Recent Development Table 82. CAVAC Company Information Table 83. CAVAC Business Overview Table 84. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 86. CAVAC Recent Development Table 87. Ceva Santé Animale Company Information Table 88. Ceva Santé Animale Business Overview Table 89. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 91. Ceva Santé Animale Recent Development Table 92. HIPRA Company Information Table 93. HIPRA Business Overview Table 94. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 96. HIPRA Recent Development Table 97. Jinyu Bio-Technology Company Information Table 98. Jinyu Bio-Technology Business Overview Table 99. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 101. Jinyu Bio-Technology Recent Development Table 102. Sinopharm Animal Health Co., Ltd Company Information Table 103. Sinopharm Animal Health Co., Ltd Business Overview Table 104. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 106. Sinopharm Animal Health Co., Ltd Recent Development Table 107. Zoetis Company Information Table 108. Zoetis Business Overview Table 109. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 111. Zoetis Recent Development Table 112. Harbin Pharmaceutical Group Company Information Table 113. Harbin Pharmaceutical Group Business Overview Table 114. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 116. Harbin Pharmaceutical Group Recent Development Table 117. Merck Company Information Table 118. Merck Business Overview Table 119. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 121. Merck Recent Development Table 122. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 124. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2026) Table 125. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 127. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 129. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country (2021-2026) Table 130. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share Forecast by Country (2027-2032) Table 132. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 134. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2026) Table 135. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 137. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country (2021-2026) Table 140. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country (2021-2026) Table 150. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share Forecast by Country (2027-2032) Table 152. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 154. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2026) Table 155. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country (2021-2026) Table 160. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country (2021-2026) Table 170. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List Table 175. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Image Figure 2. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2021-2032) & (K Units) Figure 5. CH-1R Strain Image Figure 6. Global CH-1R Strain Sales YoY Growth (2021-2032) & (K Units) Figure 7. PC Strain Image Figure 8. Global PC Strain Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Gilts Image Figure 26. Global Gilts Sales YoY Growth (2021-2032) & (K Units) Figure 27. Sows Image Figure 28. Global Sows Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • CH-1R Strain
  • PC Strain
  • Others
Applications
  • Gilts
  • Sows
Companies covered
  • Bioveta
  • Boehringer Ingelheim
  • CAVAC
  • Ceva Santé Animale
  • HIPRA
  • Jinyu Bio-Technology
  • Sinopharm Animal Health Co., Ltd
  • Zoetis
  • Harbin Pharmaceutical Group
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Type
  6. 1.3.1 CH-1R Strain
  7. 1.3.2 PC Strain
  8. 1.3.3 Others
  9. 1.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type
  10. 1.4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
  2. 2.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers
  3. 2.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges
  4. 2.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (2021-2026)
  4. 3.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company, Product Type & Application
  7. 3.7 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Tier 1, Tier 2, and Tier 3
4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Regional Status and Outlook
  1. 4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size by Region
  3. 4.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Application
  1. 5.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Application
  2. 5.1.1 Gilts
  3. 5.1.2 Sows
  4. 5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application
  5. 5.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bioveta
  2. 6.1.1 Bioveta Company Information
  3. 6.1.2 Bioveta Business Overview
  4. 6.1.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  6. 6.1.5 Bioveta Recent Developments
  7. 6.2 Boehringer Ingelheim
  8. 6.2.1 Boehringer Ingelheim Company Information
  9. 6.2.2 Boehringer Ingelheim Business Overview
  10. 6.2.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  12. 6.2.5 Boehringer Ingelheim Recent Developments
  13. 6.3 CAVAC
  14. 6.3.1 CAVAC Company Information
  15. 6.3.2 CAVAC Business Overview
  16. 6.3.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  18. 6.3.5 CAVAC Recent Developments
  19. 6.4 Ceva Santé Animale
  20. 6.4.1 Ceva Santé Animale Company Information
  21. 6.4.2 Ceva Santé Animale Business Overview
  22. 6.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  24. 6.4.5 Ceva Santé Animale Recent Developments
  25. 6.5 HIPRA
  26. 6.5.1 HIPRA Company Information
  27. 6.5.2 HIPRA Business Overview
  28. 6.5.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  30. 6.5.5 HIPRA Recent Developments
  31. 6.6 Jinyu Bio-Technology
  32. 6.6.1 Jinyu Bio-Technology Company Information
  33. 6.6.2 Jinyu Bio-Technology Business Overview
  34. 6.6.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  36. 6.6.5 Jinyu Bio-Technology Recent Developments
  37. 6.7 Sinopharm Animal Health Co., Ltd
  38. 6.7.1 Sinopharm Animal Health Co., Ltd Company Information
  39. 6.7.2 Sinopharm Animal Health Co., Ltd Business Overview
  40. 6.7.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  42. 6.7.5 Sinopharm Animal Health Co., Ltd Recent Developments
  43. 6.8 Zoetis
  44. 6.8.1 Zoetis Company Information
  45. 6.8.2 Zoetis Business Overview
  46. 6.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  48. 6.8.5 Zoetis Recent Developments
  49. 6.9 Harbin Pharmaceutical Group
  50. 6.9.1 Harbin Pharmaceutical Group Company Information
  51. 6.9.2 Harbin Pharmaceutical Group Business Overview
  52. 6.9.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  54. 6.9.5 Harbin Pharmaceutical Group Recent Developments
  55. 6.10 Merck
  56. 6.10.1 Merck Company Information
  57. 6.10.2 Merck Business Overview
  58. 6.10.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  60. 6.10.5 Merck Recent Developments
7 North America by Country
  1. 7.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country
  2. 7.1.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  6. 7.2.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country
  2. 8.1.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  6. 8.2.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country
  2. 10.1.1 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  6. 10.2.1 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Analysis
  2. 12.1.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process
  7. 12.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
  10. 12.2.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst